What's new

Human medicines European public assessment report (EPAR): Avastin, bevacizumab, Date of authorisation: 12/01/2005, Revision: 65, Status: Authorised

Human medicines European public assessment report (EPAR): Avastin, bevacizumab, Date of authorisation: 12/01/2005, Revision: 65, Status: Authorised

Apr 25, 2025 - 13:03
 0
Human medicines European public assessment report (EPAR): Avastin, bevacizumab, Date of authorisation: 12/01/2005, Revision: 65, Status: Authorised
Human medicines European public assessment report (EPAR): Avastin, bevacizumab, Date of authorisation: 12/01/2005, Revision: 65, Status: Authorised
Read More

Tags:

Previous Article

U.S. hotel construction declined for third consecutive month

Next Article

Famed Viennese Design Hotel Reopens as Radisson Blu Das Triest Hotel, Vienna

Related Posts

Herbal medicinal product: Hederae helicis folium, Hedera helix L., F: Assessment finalised

Herbal medicinal product: Hederae helicis folium, Heder...

Feb 28, 2025  0

Human medicines European public assessment report (EPAR): Sugammadex Amomed, sugammadex, Date of authorisation: 10/01/2023, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 25, 2025  0

PSUSA/00001761/202404

PSUSA/00001761/202404

Mar 7, 2025  0